Silvestre Vicent
Instituto de Salud Carlos III(ES)Unidad de Investigación en cuidados y servicios de salud (Investén-isciii)(ES)Navarre Institute of Health Research(ES)Clinica Universidad de Navarra(ES)Centro de Investigación Biomédica en Red de Cáncer(ES)Universidad de Navarra(ES)
Publications by Year
Research Areas
RNA modifications and cancer, Cancer Cells and Metastasis, Pancreatic and Hepatic Oncology Research, Lung Cancer Treatments and Mutations, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target(2018)300 cited
- → A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis(2017)248 cited
- → An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer(2017)186 cited
- → ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours(2004)186 cited
- → A Meta-analysis of Lung Cancer Gene Expression Identifies PTK7 as a Survival Gene in Lung Adenocarcinoma(2014)158 cited
- → Elevated NSD3 histone methylation activity drives squamous cell lung cancer(2021)149 cited